Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities
* Maternal hospitalization
* Acquisition of the informed consent form signed by the patient
Exclusion Criteria:
* Refusal of the patient to participa…
Inclusion Criteria:
* Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities
* Maternal hospitalization
* Acquisition of the informed consent form signed by the patient
Exclusion Criteria:
* Refusal of the patient to participate in the study
* Presence of hypogalactia or agalactia in the patient
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.